                         SEQUENCE LISTING

<110>  Chrysalis BioTherapeutics
 
<120>  TP508 ACUTE THERAPY FOR PATIENTS WITH RESPIRATORY VIRUS INFECTION

<130>  CHBI-P0002WO

<150>  63/006,492
<151>  2020-04-07

<160>  23    

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  1

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Cys Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val 
            20              


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  2

Cys Glu Gly Asp Ser Gly Gly Pro Phe Val 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is Phe, Met, Leu, His or Val

<400>  3

Cys Xaa Gly Asp Ser Gly Gly Pro Xaa Val 
1               5                   10  


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is Phe, Met, Leu, His or Val

<400>  4

Arg Gly Asp Ala Cys Xaa Gly Asp Ser Gly Gly Pro Xaa Val 
1               5                   10                  


<210>  5
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  5

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Cys Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val 
            20              


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  6

Arg Gly Asp Ala Cys Glu Gly Asp Ser Gly Gly Pro Phe Val 
1               5                   10                  


<210>  7
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  7

Asp Asn Met Phe Cys Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly 
1               5                   10                  15      


Asp Ala Cys Glu Gly Asp Ser Gly Gly Pro Phe Val Met Lys Ser Pro 
            20                  25                  30          


Phe 
    


<210>  8
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  X is Phe, Met, Leu, His or Val

<400>  8

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Cys Xaa Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Xaa Val 
            20              


<210>  9
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  X is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  X is Phe, Met, Leu, His or Val

<400>  9

Asp Asn Met Phe Cys Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly 
1               5                   10                  15      


Asp Ala Cys Xaa Gly Asp Ser Gly Gly Pro Xaa Val Met Lys Ser Pro 
            20                  25                  30          


Phe 
    


<210>  10
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is Ala, Gly, Ser or an S-protected Cysteine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is Phe, Met, Leu, His or Val

<400>  10

Arg Gly Asp Ala Xaa Xaa Gly Asp Ser Gly Gly Pro Xaa Val 
1               5                   10                  


<210>  11
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is Ala, Gly, Ser or an S-protected cysteine.

<400>  11

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Xaa Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val 
            20              


<210>  12
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is Ala, Gly, Ser or an S-protected cysteine.

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  X is Phe, Met, Leu, His or Val

<400>  12

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Xaa Xaa Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Xaa Val 
            20              


<210>  13
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  13

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Ala Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val 
            20              


<210>  14
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  14

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Ala Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val 
            20              


<210>  15
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  15

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Ser Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val 
            20              


<210>  16
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is Ala, Gly, Ser, or an S-protected cysteine

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  X is Ala, Gly, Ser, or an S-protected cysteine

<400>  16

Asp Asn Met Phe Xaa Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly 
1               5                   10                  15      


Asp Ala Xaa Glu Gly Asp Ser Gly Gly Pro Phe Val Met Lys Ser Pro 
            20                  25                  30          


Phe 
    


<210>  17
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is Ala, Gly, Ser, or an S-protected cysteine

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  X is Ala, Gly, Ser, or an S-protected cysteine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  X is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (27)..(27)
<223>  X is Phe, Met, Leu, His or Val

<400>  17

Asp Asn Met Phe Xaa Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly 
1               5                   10                  15      


Asp Ala Xaa Xaa Gly Asp Ser Gly Gly Pro Xaa Val Met Lys Ser Pro 
            20                  25                  30          


Phe 
    


<210>  18
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  18

Asp Asn Met Phe Ala Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly 
1               5                   10                  15      


Asp Ala Ala Glu Gly Asp Ser Gly Gly Pro Phe Val Met Lys Ser Pro 
            20                  25                  30          


Phe 
    


<210>  19
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  19

Asp Asn Met Phe Ala Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly 
1               5                   10                  15      


Asp Ala Ala Glu Gly Asp Ser Gly Gly Pro Phe Val Met Lys Ser Pro 
            20                  25                  30          


Phe 
    


<210>  20
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  20

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Cys Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val Met Lys Ser Pro Phe Asn Asn Arg Trp 
            20                  25                  30          


Tyr 
    


<210>  21
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is Glu or Gln

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  X is Phe, Met, Leu, His or Val

<400>  21

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Cys Xaa Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Xaa Val Met Lys Ser Pro Phe Asn Asn Arg Trp 
            20                  25                  30          


Tyr 
    


<210>  22
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  22

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Cys Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val Met Lys Ser Pro Phe Asn Asn Arg Trp 
            20                  25                  30          


Tyr 
    


<210>  23
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  23

Ala Gly Tyr Lys Pro Asp Glu Gly Lys Arg Gly Asp Ala Cys Glu Gly 
1               5                   10                  15      


Asp Ser Gly Gly Pro Phe Val Met Lys Ser Pro Phe Asn Asn Arg Trp 
            20                  25                  30          


Tyr 
    


